This is an extended learning activity. Read the longer CPD article here.

Learning objectives

After successful completion of this CPD activity, pharmacists should be able to:

  • Discuss comorbidity considerations that need to be made when choosing antiretroviral therapy for HIV
  • Describe key factors for consideration when switching antiretroviral therapy
  • Explain the pharmacist’s role in supporting people living with HIV who also have comorbidities or coinfections.

Competency (2016) Standards addressed:  1.1, 1.4, 1.5, 2.2, 3.1, 3.5

Already read the extended learning activity in the journal? Scroll to the bottom to SUBMIT ANSWERS.

This extended learning activity is designed to extend the learner and incorporate additional reading and research by the learner. Further reading and research is required from:

Complex case

Peter is a 48-year-old male who has been living with well-controlled human immunodeficiency virus (HIV) for 10 years. Since his diagnosis he has been managed with atazanavir/cobicistat (previously atazanavir and ritonavir) and abacavir/lamivudine, and has maintained an undetectable viral load. His medical history also includes hypertension, major depression and schizophrenia.

Peter is overweight (BMI 28 kg/m2) and drinks >6 standard drinks per day. He was a heavy smoker for many years but quit 6 months ago. 

He was started on atorvastatin 20 mg once daily for hyperlipidaemia 2 days ago. 

Current medication list:

  • Atazanavir 300 mg/cobicistat 150 mg orally once daily 
  • Abacavir 600 mg/lamivudine 300 mg orally once daily
  • Perindopril 4 mg orally once daily
  • Quetiapine 100 mg orally at night
  • Escitalopram 20 mg orally once daily
  • Atorvastatin 20 mg orally once daily.

This article is accredited for group 2 CPD credits. Click submit answers to complete the quiz and automatically record CPD against your record.

SUBMIT ANSWERS

If you do get an enrolment error, please click here

ALISON DUNCAN BPharm, GradDipClinPharm, MSHP is a Senior Clinical Pharmacist and Team Leader working at the Alfred Hospital and Melbourne Sexual Health Centre. She has a passionate interest in infectious diseases.

KATE MACKIE BPharm, GradDipClinPharm, MSHP, BCGP is a Senior Clinical Pharmacist at Alfred Health, Melbourne Health and Barwon Health.

STAV MANTAS BPharm (Hons), MSHP is a Senior Clinical Pharmacist at Monash Health with 15 years’ experience in the HIV setting. She set up the HIV outpatient pharmacy service and is an integral member of the multidisciplinary team.

Conflict of interest

Alfred Health received funding from Gilead Sciences and ASHM (with support from ViiV Healthcare) to lead the Pharmacist Review of Medications for People Living with HIV seen in General Practice (PROM-GP) study.